Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Codexis, Inc. (CDXS)

11.44   1.01 (9.68%) 06-26 22:01
Open: 10.43 Pre. Close: 10.43
High: 11.44 Low: 10.52
Volume: 1,598,046 Market Cap: 747(M)
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.44 - 11.48 11.48 - 11.52
Low: 10.41 - 10.46 10.46 - 10.5
Close: 11.36 - 11.43 11.43 - 11.5

Technical analysis

as of: 2022-06-24 4:38:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 13.36     One year: 15.6
Support: Support1: 9.38    Support2: 8.1
Resistance: Resistance1: 11.43    Resistance2: 13.36
Pivot: 9.49
Moving Average: MA(5): 9.99     MA(20): 9.74
MA(100): 15.32     MA(250): 22.68
MACD: MACD(12,26): -0.4     Signal(9): -0.7
Stochastic oscillator: %K(14,3): 84.9     %D(3): 65.6
RSI: RSI(14): 59.8
52-week: High: 42  Low: 8.1
Average Vol(K): 3-Month: 875 (K)  10-Days: 901 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CDXS ] has closed above the upper band by 12.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 28.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
Codexis to Participate in Upcoming Healthcare Conferences -

Fri, 24 Jun 2022
Is Codexis, Inc. (CDXS) a Good Choice in Biotechnology Friday? - InvestorsObserver

Fri, 17 Jun 2022
Codexis rises 8% on publication of research for protein modification (NASDAQ:CDXS) - Seeking Alpha

Wed, 15 Jun 2022
Codexis (NASDAQ:CDXS) Sets New 12-Month Low at $8.68 - Defense World

Mon, 06 Jun 2022
Even though Codexis (NASDAQ:CDXS) has lost US$59m market cap in last 7 days, shareholders are still up 118% over 5 years - Simply Wall St

Sat, 04 Jun 2022
Companies Like Codexis (NASDAQ:CDXS) Are In A Position To Invest In Growth - Yahoo Movies UK

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 65 (M)
Shares Float 56 (M)
% Held by Insiders 2.4 (%)
% Held by Institutions 106.4 (%)
Shares Short 4,990 (K)
Shares Short P.Month 4,810 (K)

Stock Financials

EPS -0.24
EPS Est Next Qtl 0.05
EPS Est This Year -0.42
EPS Est Next Year -0.16
Book Value (p.s.) 2.6
Profit Margin (%) -20.4
Operating Margin (%) -21.7
Return on Assets (ttm) -6.1
Return on Equity (ttm) -12.8
Qtrly Rev. Growth 16.5
Gross Profit (p.s.) 0.41
Sales Per Share 1.61
EBITDA (p.s.) -0.31
Qtrly Earnings Growth 0
Operating Cash Flow -14 (M)
Levered Free Cash Flow -14 (M)

Stock Valuations

PE Ratio -47.67
PEG Ratio -1.5
Price to Book value 4.38
Price to Sales 7.08
Price to Cash Flow -52.02

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.